Flublok Approval History
FDA Approved: Yes (First approved January 16, 2013)
Brand name: Flublok
Generic name: influenza vaccine
Dosage form: Injection
Company: Protein Sciences Corp.
Treatment for: Influenza Prophylaxis
Flublok (influenza vaccine, recombinant hemagglutinin) is an influenza vaccine indicated for active immunization against seasonal influenza in adults 18 years of age and older .
Flublok is manufactured using modern cell culture technology, and does not contain any preservatives (e.g., thimerosal, which contains mercury), egg proteins, gelatin or latex.
Flublok is administered via intramuscular (IM) injection annually prior to flu season. The most commonly reported side effect is pain at the injection site. Headache, fatigue or muscle aches may also occur.
Development History and FDA Approval Process for Flublok
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.